Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter
Thanks for your interest in this podcast. Please read this important program…
Thanks for your interest in this podcast. Please read this important program…
The 2nd International Glaucoma Symposium underscores how AI and advanced imaging are…
(Image Credit: AdobeStock/littlewolf1989) A press release from Mass General Brigham, Boston, reported…
Since February 2023, the FDA and various companies have been actively initiating…
Astellas Pharma has signed a license agreement that grants them the rights…
Researchers have successfully developed a groundbreaking synthetic protein to treat macular degeneration…
Pixium Vision SA has announced the reception of a €1.8 million Research…
Iveric Bio, an Astellas Company, has joined forces with Eric Stonestreet, a…
After observing discouraging phase 2 clinical data, Novartis has opted to terminate…
What Is Bull’s Eye Maculopathy? Bull’s Eye Maculopathy is a specific form…
The U.S. Centers for Medicare & Medicaid Services (CMS) have officially designated…
Repeat corticosteroid injections were found to be more effective in improving vision…
Enter your email address below and subscribe to our newsletter